Skip to main content

Table 2 Results of platelet aggregometry assays

From: Better detection of platelet aggregation in patients with metabolic syndrome using epinephrine and ADP

 

Healthy individuals

Patients with MS%

P

 

(n = 53)

(n = 56)

 

ADP 2.34 μM

61.4 ± 11.7

59.2 ± 8.9

0.2739

ADP 1.17 μM

53.8 ± 12.3

32.4 ± 19.9

0.0001*

ADP 0.58 μM

38.5 ± 8.85

43.5 ± 7.2

0.0017*

Epinephrine 11.0 μM

47.4 ± 15.0

84.0 ± 30.8

<0.0001*

Epinephrine 1.1 μM

36.4 ± 15.2

14.8 ± 17.3

<0.0001*

Epinephrine 0.55 μM

17.4 ± 4.7

26.8 ± 7.7

<0.0001*

  1. ADP adenosine diphosphate, MS metabolic syndrome. All values are presented as mean ± SD. Differences between groups were estimated using a Unpaired t test with Welch's correction. *statistically significant.